12 August 2025
12 August 2025
Vinay Prasad resumes leadership at the FDA鈥檚 CBER two weeks after he resigned amid cell and gene therapy controversy.
Fosun Pharma will retain the rights to develop, manufacture and commercialise XH-S004 in some specific regions.
WeightWatchers is now only offering Wegovy while other telehealth providers defiantly hang on to compounded alternatives.
As tariffs on drug imports from the EU look set to alter pricing and manufacturing strategies, each entity needs to study its full impact.
This will be the first time the option has been taken up since it was introduced at the beginning of 2025, under the Medical Research Act.
Nanotein鈥檚 NanoSpark reagents improve cell activation and expansion in cell therapy manufacturing.
If approved, gepotidacin would offer a new treatment option against resistant forms of gonorrhoea.
Fosun Pharma will retain the rights to develop, manufacture and commercialise XH-S004 in some specific regions.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
